Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Please see the latest updates concerning our response to coronavirus.

Mini tumours help predict how cancer handles the heat of innovative cancer treatments

Scientists have shown that therapies which combine heat and radiation have a different effect on lab-grown mini tumours than they do on lab-grown cancer cells grown in a more traditional way in a two-dimensional layer.
Read more
Pioneer in building collaboration across research fields joins as Scientific Director of the Cancer Research UK Convergence Science Centre

The ICR and Imperial College London have appointed a leading expert in building interdisciplinary partnerships to head our joint Convergence Science Centre.
Read more
Let’s finish it: Centre for Cancer Drug Discovery Appeal

We are creating a new state-of-the art drug discovery centre to create more and better drugs for cancer patients. The centre is a £75m build – and we now have less than £2m to raise. To make our building a reality, we urgently need your philanthropic support.
Support us
ASCO 2020: UK-first study shows feasibility of genetic screening for prostate cancer

Genetic screening for prostate cancer in GP surgeries could be effective at picking up otherwise undiagnosed cases of the disease, a new pilot study shows.
Read more
Thousands of lives could be lost to delays in cancer surgery during COVID-19 pandemic

Delays to cancer surgery and other treatment caused by the coronavirus crisis could result in thousands of additional deaths linked to the pandemic in England, a major new study reports.
Read more

1/5

Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Find out more
Winner of Queen's Anniversary Prize

The ICR has been recognised with a highly prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Read more
Making it count

We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
Find out more
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Find out more
Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Find out more
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Find out more